• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters1
Displaying 9-23 of 155 results

8 Rehearing Request in re Petition Institution Decision Denied: PETITIONER¿¿¿S REQUEST FOR REHEARING PURSUANT TO 37 CFR ¿¿ 4271d

Document IPR2019-00449, No. 8 Rehearing Request in re Petition Institution Decision Denied - PETITIONER¿¿¿S REQUEST FOR REHEARING PURSUANT TO 37 CFR ¿¿ 4271d (P.T.A.B. Sep. 3, 2019)
The Board noted that Petitioner relied on its earlier anticipation arguments and that, significantly, Petitioner was relying on its argument that “none of the recited [ethanol and benzyl alcohol] ranges…have been shown to have any criticality ...
cite Cite Document
Analyze

6 Notice: Patent Owners Mandatory Notices

Document IPR2019-00449, No. 6 Notice - Patent Owners Mandatory Notices (P.T.A.B. May. 21, 2019)
The patent owner provides the following notice pursuant to 37 CFR §42.8(a)(2).
Real parties-in-interest [no change] Neurelis, Inc. (“Neurelis”) owns the involved patent.
Related matters [no change] The petitioner has filed two additional inter partes review petitions (IPR2019-00450 and IPR2019-00451) against the involved patent.
Neurelis has an application (15/470,498) that claims benefit under 35 U.S.C. 120 to the application that issued as the involved patent.
Date: 21 May 2019 /Richard Torczon/ Richard Torczon Reg. No. 34,448
cite Cite Document
Analyze

5 Preliminary Response: Patent Owners Preliminary Response

Document IPR2019-00449, No. 5 Preliminary Response - Patent Owners Preliminary Response (P.T.A.B. May. 6, 2019)
Claims 8-10 and 15 deserve their claimed priority Aquestive contends that “[w]hile Cartt’865 does disclose that alcohols may be present in the following ranges (all prefaced with ‘about’), none of the following disclosed ranges correspond ...
cite Cite Document
Analyze

4 Mandatory Notice: Patent Owners Mandatory Notices

Document IPR2019-00449, No. 4 Mandatory Notice - Patent Owners Mandatory Notices (P.T.A.B. Feb. 19, 2019)
The patent owner provides the following notice pursuant to 37 CFR §42.8(a)(2).
Real parties-in-interest Neurelis, Inc. (“Neurelis”) owns the involved patent.
Related matters The petitioner has filed two additional inter partes review petitions
Neurelis has an application (15/470,498) that claims benefit under 35 U.S.C. 120 to the application that issued as the involved patent.
above counsel, is of record for the involved patent.
cite Cite Document
Analyze

1 Power of Attorney: Power of Attorney

Document IPR2019-00449, No. 1 Power of Attorney - Power of Attorney (P.T.A.B. Jan. 28, 2019)
In accordance with 37 CPR.
I have authority to sign this document on behalf of Petitioner Aquestive ra eutics, Inc. Mar Schobel Aquestive Therapeutics, Inc.
Title: Chief Innovation & Technology Officer I] te
cite Cite Document
Analyze

2001 Exhibit: Centers for Disease Control and Prevention, Epilepsy Fast Facts 9 Ap...

Document IPR2019-00449, No. 2001-67 Exhibit - Centers for Disease Control and Prevention, Epilepsy Fast Facts 9 Apr 2019, available at httpswwwcdcgovepilepsyaboutfast factshtmCDC AA refValhttps%...

cite Cite Document
Analyze

2003 Exhibit: Howard LeWine, MD, Quick Injection Helps Stop Epileptic Seizures, H...

Document IPR2019-00449, No. 2003-69 Exhibit - Howard LeWine, MD, Quick Injection Helps Stop Epileptic Seizures, Harvard Health Blog 23 Feb 2012, available at httpswwwhealthharvard edublogquick in...

cite Cite Document
Analyze

2004 Exhibit: Centers for Disease Control and Prevention, Putting Collective Wisdo...

Document IPR2019-00449, No. 2004-70 Exhibit - Centers for Disease Control and Prevention, Putting Collective Wisdom to Work for People with Epilepsy Nov 2016 (P.T.A.B. May. 6, 2019)

cite Cite Document
Analyze

2002 Exhibit: Food Drug Administration, Grant Fast Track IND 112621 NRL 1 diaze...

Document IPR2019-00449, No. 2002-68 Exhibit - Food Drug Administration, Grant Fast Track IND 112621 NRL 1 diazepam intranasal solution 27 Dec 2016 (P.T.A.B. May. 6, 2019)

cite Cite Document
Analyze

2005 Exhibit: KM Fiest et al, Prevalence and Incidence of Epilepsy, A Systematic R...

Document IPR2019-00449, No. 2005-71 Exhibit - KM Fiest et al, Prevalence and Incidence of Epilepsy, A Systematic Review and Meta Analysis of International Studies, 88 Neurology 296 17 Jan 2017 (P.T...

cite Cite Document
Analyze

1004 Exhibit: Part 7 Pages 2101 2450 File History for 546 Patent, Ser No 13495,94...

Document IPR2019-00449, No. 1004-11 Exhibit - Part 7 Pages 2101 2450 File History for 546 Patent, Ser No 13495,942 546 FH (P.T.A.B. Jan. 28, 2019)

cite Cite Document
Analyze

1020 Exhibit: Meezan et al, US Patent No 5,661,130, Absorption Enhancers For Dr...

Document IPR2019-00449, No. 1020-36 Exhibit - Meezan et al, US Patent No 5,661,130, Absorption Enhancers For Drug Administration, issued August 26, 1997 Meezan130 (P.T.A.B. Jan. 28, 2019)

cite Cite Document
Analyze

1014 Exhibit: Gwozdz et al, WO 2009120933, Pharmaceutical Solutions And Metho...

Document IPR2019-00449, No. 1014-30 Exhibit - Gwozdz et al, WO 2009120933, Pharmaceutical Solutions And Method For Solubilizing Therapeutic Agents, published October 1, 2009, International Filing...

cite Cite Document
Analyze

1046 Exhibit: Provisional Patent Application No 61040,281, Pharmaceutical Solutio...

Document IPR2019-00449, No. 1046-64 Exhibit - Provisional Patent Application No 61040,281, Pharmaceutical Solutions and Method for Solubilizing Therapeutics Agents, filed March 28, 2008, Gwozdz, G...

cite Cite Document
Analyze

1035 Exhibit: Davis, Delivery of peptide and non peptide drugs through the respirat...

Document IPR2019-00449, No. 1035-51 Exhibit - Davis, Delivery of peptide and non peptide drugs through the respiratory tract, Pharmaceutical Science Technology Today, Vol 2, No 11 November 1999, p...

cite Cite Document
Analyze
<< 1 2 3 4 5 ... 9 10 11 >>